Trials / Completed
CompletedNCT02484898
SEEQ™ Performance Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).
Conditions
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2016-04-01
- Completion
- 2016-08-01
- First posted
- 2015-06-30
- Last updated
- 2016-11-22
- Results posted
- 2016-11-22
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02484898. Inclusion in this directory is not an endorsement.